Search results
Dr. Phil's staged interview with Donald Trump is a sign of the grim political theater to come
Salon.com· 3 days agoEach day, the Age of Trump provides more evidence in support of the argument by scientists and...
Will you scoot by on coverage? The uncertainty of insurance for electric scooters
Reuters· 4 days agoIn 2017, electric scooter startup Bird Rides dropped hundreds of electric scooters in Santa Monica,...
Queer comedians take center stage in Netflix documentary ‘Outstanding’
NBC Universal via AOL· 6 days agoIn the new Netflix documentary "Outstanding," Margaret Cho, Judy Gold, Robin Tyler and other comedy...
Who is Donald Trump's reclusive new mega-donor, Timothy Mellon?
BBC News· 3 days agoWho is Trump's new mega-donor, Timothy Mellon? An octogenarian billionaire scion of one of America's...
3 Penny Stocks Foretelling a Future of Extraordinary Gains
InvestorPlace· 4 days agoPenny stocks get a bad rep due to their volatility, and many investors choose to stay away. Given...
Metro Council nixes rezoning request for large East End development - Louisville Business First
The Business Journals· 3 days agoThe developers of a 65,000-square-foot shopping center wanted to switch the zoning of the...
Thai same-sex marriage bill clears final hurdle with Senate
Pittsburgh Tribune-Review· 6 days agoThailand’s same-sex marriage bill cleared its final hurdle with the Senate endorsing it in a special...
Capito leads Senate in deciding nuclear reward outweighs health, security risks
The Charleston Gazette· 3 days agoIt might get easier for West Virginia — and the rest of the country — to go nuclear. The...
Charlie Baker’s belated win
Politico· 4 days agoWade, The Eagle-Tribune: “The state Division of Insurance is reviewing proposals from large commercial insurers to increase premium rates by an average of 8.4% next year for ...
Sarepta surges as investors cheer expanded use of gene therapy
Reuters via Yahoo News· 3 days ago(Reuters) -Sarepta Therapeutics shares surged as much as 40% to a more than three-year high on Friday as an expanded use approval cemented its dominant position in the gene therapy market for ...
